Integrated Urinalysis Devices Based on Interface‐Engineered Field‐Effect Transistor Biosensors Incorporated With Electronic Circuits

Biosensing Techniques Cystoscopy 02 engineering and technology Urinalysis 6. Clean water 3. Good health Urinary Bladder Neoplasms Biomarkers, Tumor Humans Electronics Neoplasm Recurrence, Local Zinc Oxide 0210 nano-technology
DOI: 10.1002/adma.202203224 Publication Date: 2022-07-19T23:48:25Z
ABSTRACT
Urinalysis is attractive in non-invasive early diagnosis of bladder cancer compared with clinical gold standard cystoscopy. However, the trace tumor biomarkers urine and particularly complex environment pose significant challenges for urinalysis. Here, a clinically adoptable urinalysis device that integrates molecular-specificity indium gallium zinc oxide field-effect transistor (IGZO FET) biosensor arrays, control panel, an internet terminal directly analyzing five bladder-tumor-associated proteins samples, reported classification. The IGZO FET biosensors engineered sensing interfaces provide high sensitivity selectivity identification environment. Integrating machine-learning algorithm, this can identify accuracy 95.0% cohort 197 patients 75 non-bladder individuals, distinguishing stages overall 90.0% assessing recurrence after surgical treatment. defines robust technology remote healthcare personalized medicine.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (77)